These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9679794)

  • 1. Nurse-mediated cholesterol management compared with enhanced primary care in siblings of individuals with premature coronary disease.
    Becker DM; Raqueño JV; Yook RM; Kral BG; Blumenthal RS; Moy TF; Bezirdjian PJ; Becker LC
    Arch Intern Med; 1998 Jul; 158(14):1533-9. PubMed ID: 9679794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nurse case management of hypercholesterolemia in patients with coronary heart disease: results of a randomized clinical trial.
    Allen JK; Blumenthal RS; Margolis S; Young DR; Miller ER; Kelly K
    Am Heart J; 2002 Oct; 144(4):678-86. PubMed ID: 12360165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of a physician-directed treatment program for low-income patients with high blood cholesterol: the Southeast Cholesterol Project.
    Keyserling TC; Ammerman AS; Davis CE; Mok MC; Garrett J; Simpson R
    Arch Fam Med; 1997; 6(2):135-45. PubMed ID: 9075448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.
    Schrott HG; Bittner V; Vittinghoff E; Herrington DM; Hulley S
    JAMA; 1997 Apr 23-30; 277(16):1281-6. PubMed ID: 9109465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy.
    Allison TG; Squires RW; Johnson BD; Gau GT
    Mayo Clin Proc; 1999 May; 74(5):466-73. PubMed ID: 10319076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a community-based multiple risk factor intervention on cardiovascular risk in black families with a history of premature coronary disease.
    Becker DM; Yanek LR; Johnson WR; Garrett D; Moy TF; Reynolds SS; Blumenthal RS; Vaidya D; Becker LC
    Circulation; 2005 Mar; 111(10):1298-304. PubMed ID: 15769772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to oxidized low-density lipoprotein in patients following coronary artery revascularization.
    Miller ER; Erlinger TP; Blumenthal RS; Margolis S; Allen JK
    Coron Artery Dis; 2003 Apr; 14(2):163-9. PubMed ID: 12655280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of a public health nurse directed treatment program for rural patients with high blood cholesterol.
    Ammerman AS; Keyserling TC; Atwood JR; Hosking JD; Zayed H; Krasny C
    Prev Med; 2003 Mar; 36(3):340-51. PubMed ID: 12634025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy.
    Hunninghake DB
    Am J Med; 1998 Feb; 104(2A):9S-13S. PubMed ID: 9550501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.
    García Ruiz FJ; Marín Ibáñez A; Pérez-Jiménez F; Pintó X; Nocea G; Ahumada C; Alemao E; Yin D;
    Pharmacoeconomics; 2004; 22 Suppl 3():1-12. PubMed ID: 15669149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid attainment among patients newly treated with lipid-altering drugs.
    Hess G; Chang CL; Chung K
    Curr Med Res Opin; 2014 Sep; 30(9):1743-56. PubMed ID: 24889282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol goal attainment in patients with coronary heart disease and elevated coronary risk: results of the Hong Kong hospital audit study.
    Lee KK; Lee VW; Chan WK; Lee BS; Chong AC; Wong JC; Yin D; Alemao E; Tomlinson B
    Value Health; 2008 Mar; 11 Suppl 1():S91-8. PubMed ID: 18387073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of early lipid-lowering intervention in high-risk patients: the lipid intervention strategies for coronary patients study.
    Pedersen TR; Jahnsen KE; Vatn S; Semb AG; Kontny F; Zalmai A; Nerdrum T
    Clin Ther; 2000 Aug; 22(8):949-60. PubMed ID: 10972631
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.